Advanced search
Publication Cover
Pathology Volume 33, 2001 - Issue 3
Submit an article Journal homepage
9
Views
0
CrossRef citations to date
0
Altmetric
Research Article

TIMELY TOPIC: PREMALIGNANT LESIONS ASSOCIATED WITH ADENOCARCINOMA OF THE UPPER GASTROINTESTINAL TRACT

Andrew D. Clouston Department of Pathology, University of Queensland, Australia
Pages 271-277 | Published online: 06 Jul 2009

  • Spechler SJ, Goyal RK. The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. Gastroenterology 1996; 110: 614-21.
  • Weinstein WM, Ippoliti AF. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Castrointest Endosc 1996; 44: 91-5.
  • Riddell RH. The biopsy diagnosis of gastroesophageal reflux disease, "catditis," and Barren's esophagus, and sequelae of therapy. Am J Surg Pathol 1996; 20(Suppl 1): S31-50.
  • Nandurkar S, Talley NJ, Martin CJ, et al. Short segment Barren's oesophagus: prevalence, diagnosis and associations. Gut 1997; 40: 710-5.
  • Offner FA, Lewin KJ, Weinstein WM. Metaplastic columnar cells in Barren's esophagus: a common and neglected cell type. Hum Pathol 1996; 27: 885-9.
  • Chen YY, Wang HH, Antonioli DA, et al. Significance of acid-mucinpositive nongoblet columnar cells in the distal esophagus and gastroesophageal junction. Hum Pathol 1999; 30: 1488-95.
  • Weston AP, Krmpotich PT, Cherian R, et al Prospective long-term endoscopie and histdogical follow-up of short segment Barren's esophagus: comparison with traditional long segment Barren's esophagus. Am J Gastroenterol 1997; 92: 407-13.
  • Krishnamurthy S, Dayal Y. Pancreatic metaplasia in Barren's esophagus. An immuno-histochemical study. Am J Surg Pathol 1995; 19: 1172-80.
  • Wang HH, Zercogian JM, Spechler SJ, et al. Prevalence and significance of pancreatic acinar metaplasia at the gastroesophageal junction. Am J Surg Pathol 1996; 2ft 1507-10.
  • Boch JA, Shields HM, Antonioli DA, et at. Distribution of cytokerati n markers in Barren's specialized columnar epithelium. Gastroenterology 1997; 112:760-5.
  • Takubo K, Sasajima K, Yamashita K, et al Double muscularis mucosae in Barren's esophagus. Hum Pathol 1991; 22: 1158-61.
  • Ormsby AH, Goldblum JR, Rice TW, et al Cytokeratin subsets can reliably distinguish Barren's esophagus from intestinal metaplasia of the stomach. Hum Pathol 1999; 30: 288-94.
  • Chinyama CN, Marshall REK, Owen WJ, etal Expression of MUC1 and MUC2 mucin gene products in Barren's metaplasia, dysplasia and adenocarcinoma: an immunopathological study with clinical correlation. Histopathology 1999; 35: 517-24.
  • Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barren's oesophagus. Cut 1991; 32: 1441-6.
  • Haggitt RC. Barren's esophagus, dysplasia and adenocarcinoma. Hum Pathol 1994; 25: 982-93.
  • Ofman JJ, Lewin K, Ramers C, et al The economic impact of the diagnosis of dysplasia in Barren's esophagus. Am J Gastroenterol 2000; 95: 2946-52.
  • FaIk GW. Endoscopie surveillance of Barren's esophagus: risk stratification and cancer risk. Castrointest Endosc 1999; 49(3 Pt 2): S29-34.
  • Thurberg BL, Duray PH, Odze RD. Polypoid dysplasia in Barren's esophagus: a clinicopathdogic, immunohistochemical, and molecular study of five cases. Hum Pathol 1999; 30: 745-52.
  • Reid BJ, Levine DS, Longton G, et al Predictors of progression to cancer in Barren's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol 2000; 95: 1669-76.
  • Younes M, Ertan A, Lechago LV, et al p53 Protein accumulation is a specific marker of malignant potential in Barren's metaplasia. Dig Dis Sei 1997; 42: 697-701.
  • Ireland AP, Clark GW, DeMeester TR. Barren's esophagus. The significance of p53 in clinical practice. Ann Surg 1997; 225: 17-30.
  • Paraf F, Flejou JF, Pignon JP, et al Surgical pathology of adenocarcinoma arising in Barren's esophagus. Analysis of 67 cases. Am J Surg Pathol 1995; 19: 183-91.
  • Spechler SJ, Dixon MJ, Genta RM, et al Adenocarcinoma of the oesophago-gastric junction. In: Hamilton SR, Aaltonen LA, editors. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: 31-6.
  • Chandrasoma PT, Der R, Ma Y, et al Histology of the gastroesophageal junction: an autopsy study. Am J Surg Pathol 2000; 24: 402-9.
  • Kilgore SP, Ormsby AH, Gramlich TL, et al. The gastric cardia: fact or fiction? Am J Gastroenterol 2000; 95: 921-4.
  • Spechler SJ. The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. Gastroenterology 1999; 117: 218-28.
  • Spechler SJ, Zeroogian JM, Antonioli DA, et al Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 1994; 344: 1533-6.
  • Chalasani N, Wo JM, Hunter JG, et al Significance of intestinal metaplasia in different areas of esophagus including esophagogastric junction. Dig Dis Sei 1997; 42: 603-7.
  • Hackelsberger A, Günther T, Schultze V, et al Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 1998; 43: 17-21.
  • Günther T, Hackelsberger A, Malfertheiner P, et al Is typing of metaplasia at the squamocolumnar junction revealing its aetiology? Vtrchows Arch 2000; 436: 6-11.
  • Goldblum JR. Inflammation and intestinal metaplasia of the gastric cardia: Helicobacter pylori, gastroesophageal reflux disease, or both. Dig Dis 2000; 18: 14-9.
  • Oberg S, Peters JH, Nigro JJ, et al. Helicobacter pylori is not associated with the manifestations of gastroesophageal reflux disease. Arch Surg 1999; 134: 722-6.
  • Ormsby AH, Kilgore SP, Goldblum JR, et al. The location and frequency of intestinal metaplasia at the esophagogastric junction in 223 consecutive autopsies: implications for patient treatment and preventive strategies in Barren's esophagus. Mod PathoI 2000; 13: 614-20.
  • Weinstein WM. Precursor lesions for cancer of the cardia. Gastrointest Endosc Clin NAm 1997; 7: 19-28.
  • Rud A, Parenti A, Zaninotto G, et al Intestinal metaplasia is the probable common precursor of adenocarcinoma in Barrett esophagus and adenocarcinoma of the gastric cardia. Cancer 2000; 88: 2520-8.
  • Ireland AP, Shibata DK, Chandrasoma P, et al Clinical significance of p53 mutations in adenocarcinoma of the esophagus and cardia. Ann Surg 2000-, 231: 179-87.
  • Hirota WK, Loughney TM, Lazas DJ, et al Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data. Gastroenterology 1999; 116: 277-85.
  • Zaninotto G, Parenti AR, Ruol A, et al Oesophageal resection for high-grade dysplasia in Barren's oesophagus. Br J Surg 2000; 87: 1102-5.
  • Genta RM. Atrophy and atrophie gastritis: one step beyond the Sydney system. Ital J Gastroenterol Hepatol 1998; 30(Suppl 3): S273-5.
  • You W, Zhang L, Gail MH, et l Gastric dysplasia and gastric cancer: helicobacter pylori, serum vitamin C, and other risk factors. J Natl Cancer Inst 2000; 92: 1607-12.
  • Jass JR, Filipe MI. The mucin profiles of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma. Histochem J 1981; 13: 931-9.
  • Bronner MP. Gastric cancer and intestinal metaplasia. Hum Pathol 1999; 30: 733.
  • Schlemper RJ, ItabashiM, Kato Y, et al Differences in diagnostic criteria for gastric carcinoma between Japanese and western pathologists. Lancet 1997; 349: 1725-9.
  • Schlemper RJ, Riddell RH, Kato Y, etal The Vienna classification of gastrointestinal epithelial neoplasia. Gut 2000; 47: 251-5.
  • RuggeM, Correa P, Dixon MF, et al Gastric dysplasia: the Padova international classification. Am J Surg Pathol 2000; 24: 167-76.
  • RuggeM, Farinati F, Baffa R, etal Gastric epithelial dysplasia in the natural history of gastric cancer: a multicenter prospective follow-up study. Interdisciplinary Group on Gastric Epithelial Dysplasia. Gastroenterology 1994; 107: 1288-96.
  • Antonioli DA. Precursors of gastric carcinoma: a critical review with a brief description of early (curable) gastric cancer. Hum Pathol 1994; 25: 994-1005.
  • Fenoglio-Preiser CM, Carneiro F, Correa P, et al Gastric carcinoma. In: Hamilton SR, Aaltonen LA, editors. World Health Organisation Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: 39-52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.